This manuscript characterizes a mutated clone of RNA polymerase I in yeast, referred to as SuperPol, to understand the mechanisms of RNA polymerase I elongation and termination. The authors present ...

BDR Pharma has spent close to Rs 600 crore and plans to invest another Rs 700 crore to boost growth and acquisitions over the ...

A recent video produced by Vapourtec highlights the patented automatic Variable Bed Flow Reactor (VBFR) demonstrating fully ...

IDE849 is in an ongoing multi-site open label Phase 1 clinical trial for advanced solid tumors (NCT06443489) by Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, SHA: 600276). In this ...

Tagworks initiated first-in-human phase 1 clinical development of TGW101 in a multicenter, open-label, dose-escalation trial in patients with advanced solid tumours. The primary objectives of the ...

The scalability and reproducibility of ECO Synthesis manufacturing processes A groundbreaking machine learning tool to optimize ligase selection and fragment design An emerging capability to control ...

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor frequently expressed in solid malignancies ... effective dosimetry of 177 Lu-labeled KLG-3 therapy. Targeting with KLG-3 was ...

Microscopic imaging analysis on Alexa Fluor 647-labeled ASO and Chol-HDO. C57BL/6 mice were injected intravenously with Alexa Fluor 647-labeled ASO and Chol-HDO. At 4 h after injection, the brain ...